BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27333958)

  • 1. Aster spathulifolius Maxim extract reduces body weight and fat mass in obese humans.
    Cho IJ; Choung SY; Hwang YC; Ahn KJ; Chung HY; Jeong IK
    Nutr Res; 2016 Jul; 36(7):671-8. PubMed ID: 27333958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats.
    Kim SJ; Bang CY; Guo YR; Choung SY
    J Med Food; 2016 Apr; 19(4):353-64. PubMed ID: 26908215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of Aster spathulifolius extract on adipogenesis and lipid accumulation in 3T3-L1 preadipocytes.
    Kim SJ; Choung SY
    J Pharm Pharmacol; 2016 Jan; 68(1):107-18. PubMed ID: 26471469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.
    Halpern A; Mancini MC; Suplicy H; Zanella MT; Repetto G; Gross J; Jadzinsky M; Barranco J; Aschner P; Ramirez L; Matos AG
    Diabetes Obes Metab; 2003 May; 5(3):180-8. PubMed ID: 12681025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.
    Jensen GS; Beaman JL; He Y; Guo Z; Sun H
    Clin Interv Aging; 2016; 11():367-76. PubMed ID: 27069360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Han Y; Kwon EY; Yu MK; Lee SJ; Kim HJ; Kim SB; Kim YH; Choi MS
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germacrone Attenuates Hyperlipidemia and Improves Lipid Metabolism in High-Fat Diet-Induced Obese C57BL/6J Mice.
    Guo YR; Choung SY
    J Med Food; 2017 Jan; 20(1):46-55. PubMed ID: 28098516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.
    Bolinder J; Ljunggren Ö; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
    Diabetes Obes Metab; 2014 Feb; 16(2):159-69. PubMed ID: 23906445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
    Uebelhack R; Bongartz U; Seibt S; Bothe G; Chong PW; De Costa P; Wszelaki N
    J Obes; 2019; 2019():3412952. PubMed ID: 30863632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications.
    Snitker S; Fujishima Y; Shen H; Ott S; Pi-Sunyer X; Furuhata Y; Sato H; Takahashi M
    Am J Clin Nutr; 2009 Jan; 89(1):45-50. PubMed ID: 19056576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
    Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
    Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study).
    Hollander P; Lasko B; Barnett AH; Bengus M; Kanitra L; Pi-Sunyer FX; Balena R
    Obesity (Silver Spring); 2013 Feb; 21(2):238-47. PubMed ID: 23404788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial.
    Loftus HL; Astell KJ; Mathai ML; Su XQ
    Nutrients; 2015 Nov; 7(11):9508-22. PubMed ID: 26593941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial.
    Song J; Shin SM; Kim H
    Medicine (Baltimore); 2019 Nov; 98(45):e17922. PubMed ID: 31702673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
    Chong PW; Beah ZM; Grube B; Riede L
    Phytother Res; 2014 Oct; 28(10):1520-6. PubMed ID: 24797657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.
    Ngondi JL; Etoundi BC; Nyangono CB; Mbofung CM; Oben JE
    Lipids Health Dis; 2009 Mar; 8():7. PubMed ID: 19254366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.